• 304 Citations
  • 2 h-Index
20172018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vincenzo Di Lauro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 92 Similar Profiles
letrozole Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

  • 304 Citations
  • 2 h-Index
  • 3 Article
27 Citations (Scopus)

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

on behalf of the SOLE Investigators, Jan 1 2018, In : The Lancet Oncology. 19, 1, p. 127-138 12 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Disease-Free Survival
Therapeutics

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Colleoni, M., Luo, W., Karlsson, P., Chirgwin, J., Aebi, S., Jerusalem, G., Neven, P., Hitre, E., Graas, M. P., Simoncini, E., Kamby, C., Thompson, A., Loibl, S., Gavilá, J., Kuroi, K., Marth, C., Müller, B., O'Reilly, S., Di Lauro, V., Gombos, A. & 31 others, Ruhstaller, T., Burstein, H., Ribi, K., Bernhard, J., Viale, G., Maibach, R., Rabaglio-Poretti, M., Gelber, R. D., Coates, A. S., Di Leo, A., Regan, M. M., Goldhirsch, A., Vandebroek, A., Berliere, M., Mitine, C., Vuylsteke, P., Borms, M., D'Hondt, R., Glorieux, P., Mebis, J., Verhoeven, D., Coibion, M., Forget, F., Duck, L., Verhoeven, D., Wyendaele, W., Barbeaux, A., Salmon, J. P., Bernardo, A., Amadori, D. & on behalf of the SOLE Investigators, Jan 1 2018, In : The Lancet Oncology. 19, 1, p. 127-138 12 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Disease-Free Survival
Therapeutics

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

Von Minckwitz, G., Procter, M., de Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., Knott, A., Lang, I., Levy, C., Yardley, D. A., Bines, J., Gelber, R. D., Piccart, M., Baselga, J., Investigators], . A. M. O. APHINITY. S. C. A. & Di Lauro, V., Jul 13 2017, In : New Engl J Med. 377, 2, p. 122-131 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Trastuzumab
pertuzumab